These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10868495)

  • 21. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; del Zoppo G; Yamaguchi T
    Cochrane Database Syst Rev; 2000; (2):CD000213. PubMed ID: 10796329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
    Counsell C; Sandercock P
    Cochrane Database Syst Rev; 2000; (2):CD000119. PubMed ID: 10796301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P
    Chest; 2008 Jun; 133(6 Suppl):630S-669S. PubMed ID: 18574275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of intravenous heparin by North American neurologists: do the data matter?
    Al-Sadat A; Sunbulli M; Chaturvedi S
    Stroke; 2002 Jun; 33(6):1574-7. PubMed ID: 12052993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of ischaemic stroke.
    Masuhr F; Einhäupl K
    Thromb Haemost; 1999 Sep; 82 Suppl 1():85-91. PubMed ID: 10695494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulants for acute ischaemic stroke.
    Sandercock PA; Counsell C; Kamal AK
    Cochrane Database Syst Rev; 2008 Oct; (4):CD000024. PubMed ID: 18843603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulants for acute ischaemic stroke.
    Gubitz G; Counsell C; Sandercock P; Signorini D
    Cochrane Database Syst Rev; 2000; (2):CD000024. PubMed ID: 10796283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Head Position in the Early Phase of Acute Ischemic Stroke: An International Survey of Current Practice.
    Muñoz Venturelli P; Olavarría V; González F; Brunser A; Lavados P; Arima H; Anderson CS
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1564-9. PubMed ID: 25910872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Medical therapy in patients with carotid artery stenosis.
    Goldstein LB; Bonito AJ; Matchar DB; Duncan PW; Samsa GP
    Stroke; 1996 Sep; 27(9):1473-8. PubMed ID: 8784115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discarding heparins as treatment for progressive stroke in Sweden 2001 to 2008.
    Eriksson M; Stecksén A; Glader EL; Norrving B; Appelros P; Hulter Åsberg K; Stegmayr B; Terént A; Asplund K;
    Stroke; 2010 Nov; 41(11):2552-8. PubMed ID: 20930151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke.
    Wardlaw JM; Warlow CP; Counsell C
    Lancet; 1997 Aug; 350(9078):607-14. PubMed ID: 9288042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of heparin treatment for progressing ischaemic stroke: before and after study.
    Rödén-Jüllig A; Britton M
    J Intern Med; 2000 Oct; 248(4):287-91. PubMed ID: 11086638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The stroke pharmacopeia: current medical therapies.
    Wittkowsky AK
    Pharmacotherapy; 1998; 18(3 Pt 2):94S-100S; discussion 85S-86S. PubMed ID: 9619493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shortfall in stroke care: A study of ischaemic stroke care practices in a South African metropole.
    Mandizvidza V; London L; Bryer A
    S Afr Med J; 2021 Mar; 111(3):215-219. PubMed ID: 33944742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practice variation among Michigan neurologists in the use of intravenous heparin.
    Kudesia R; Chaturvedi S
    J Neurol Sci; 2002 Oct; 202(1-2):25-7. PubMed ID: 12220688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physician variation in the management of patients with atrial fibrillation.
    Lip GY; Zarifis J; Watson RD; Beevers DG
    Heart; 1996 Feb; 75(2):200-5. PubMed ID: 8673762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
    Williams JM; Navin TJ; Jude MR; Levi CR
    Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antithrombotic treatment in acute ischemia stroke].
    Díez-Tejedor E; Alonso de Leciñana M; Counsell C; Sandercock P
    Neurologia; 1995 Dec; 10 Suppl 2():48-54. PubMed ID: 8714450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
    Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
    N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.